Literature DB >> 12462131

A framework for describing the impact of antidepressant medications on population health status.

Scott B Patten1.   

Abstract

BACKGROUND: In the absence of strategies for primary prevention, public health initiatives for major depression have generally focused on secondary and tertiary strategies such as case-finding, public and professional education and disease management. Much emphasis has been placed on low reported rates of antidepressant utilization. In principle, increased rates of treatment utilization should lead to improved mental health status at the population level. However, methods for relating antidepressant utilization to population health status have not been described.
METHODS: An incidence-prevalence model was developed using data from a Canadian national survey, supplemented by parameter estimates from literature reviews. The lifetime sick-day proportion (LSP) was used to approximate point prevalence.
RESULTS: Mathematical simulations using this model produced reasonable approximations of point prevalence for major depression. The model suggests that an improved rate of treatment utilization may not, in itself, lead to substantially reduced prevalence. Reducing the rate of relapse in those with highly recurrent disorders, which can be accomplished by long-term antidepressant treatment, is predicted to have a more substantial impact on population health status.
CONCLUSIONS: The model presented here offers a framework for describing the impact of antidepressant treatment on population health status. Mathematical models may assist with decision-making and priority setting in the public health sphere, as illustrated by the model presented here, which challenges some commonly held assumptions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12462131     DOI: 10.1002/pds.746

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  5 in total

1.  Recommendations on screening for depression in adults.

Authors:  Michel Joffres; Alejandra Jaramillo; James Dickinson; Gabriela Lewin; Kevin Pottie; Elizabeth Shaw; Sarah Connor Gorber; Marcello Tonelli
Journal:  CMAJ       Date:  2013-05-13       Impact factor: 8.262

2.  Is screening effective in detecting untreated psychiatric disorders among newly diagnosed breast cancer patients?

Authors:  Steven C Palmer; Alison Taggi; Angela Demichele; James C Coyne
Journal:  Cancer       Date:  2011-10-11       Impact factor: 6.860

3.  Decision curve analysis as a framework to estimate the potential value of screening or other decision-making aids.

Authors:  Michael S Martin; George A Wells; Anne G Crocker; Beth K Potter; Ian Colman
Journal:  Int J Methods Psychiatr Res       Date:  2017-12-28       Impact factor: 4.035

Review 4.  Rethinking recommendations for screening for depression in primary care.

Authors:  Brett D Thombs; James C Coyne; Pim Cuijpers; Peter de Jonge; Simon Gilbody; John P A Ioannidis; Blair T Johnson; Scott B Patten; Erick H Turner; Roy C Ziegelstein
Journal:  CMAJ       Date:  2011-09-19       Impact factor: 8.262

5.  Depression screening and mental health outcomes in children and adolescents: a systematic review protocol.

Authors:  Brett D Thombs; Michelle Roseman; Lorie A Kloda
Journal:  Syst Rev       Date:  2012-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.